KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Asset Utilization Ratio (2016 - 2025)

Ionis Pharmaceuticals has reported Asset Utilization Ratio over the past 16 years, most recently at 0.15 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.15 for Q4 2025, down 35.03% from a year ago — trailing twelve months through Dec 2025 was 0.15 (down 35.03% YoY), and the annual figure for FY2025 was 0.29, up 22.89%.
  • Asset Utilization Ratio for Q4 2025 was 0.15 at Ionis Pharmaceuticals, down from 0.17 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for IONS hit a ceiling of 0.3 in Q2 2024 and a floor of 0.14 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.21 (2022), compared with a mean of 0.21.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 163.57% in 2021 and later crashed 42.86% in 2025.
  • Ionis Pharmaceuticals' Asset Utilization Ratio stood at 0.17 in 2021, then skyrocketed by 38.4% to 0.24 in 2022, then grew by 12.18% to 0.27 in 2023, then dropped by 12.84% to 0.23 in 2024, then plummeted by 35.03% to 0.15 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.15 (Q4 2025), 0.17 (Q3 2025), and 0.17 (Q2 2025) per Business Quant data.